SEC Form 4 · accession 0001225208-16-025767
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wesley W Von Schack
Director
Period of report
Feb 4, 2016
Accepted (ET)
Feb 8, 2016 · 12:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Feb 4, 2016 | S | 8,106 | $83.2347 | D | 40,130 | I | By Trust |
| Common StockF4 | holding | — | — | — | 3,652 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $83.18 to $83.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F2These shares were previously reported as directly owned and are now being reported as indirectly owned. On December 11, 2015, the common stock of the Issuer split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- F3The von Schack Revocable Trust
- F4Excludes shares that were previously reported as directly owned and are now being reported as indirectly owned. On December 11, 2015, the common stock of the Issuer split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.